Clinical trials: Epilepsy, completed
Generalized Tonic Clonic Seizures
A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.
The study is designed to evaluate the safety, tolerability and efficacy of two doses of pregabalin as add-on treatment in pediatric and adult subjects with Primary Generalized Tonic-Clonic (PGTC) seizures as compared to placebo.
- Trial name
- NCT01747915
- Testing
- Pregabalin Dose Level 1, Pregabalin Dose Level 2
- Where
- 127 sites in United States, Austria and 24 more
- Volunteers
- 219 people
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Epilepsy, Partial Seizure Disorder
Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures
To compare the efficacy of pregabalin and gabapentin, as adjunctive therapy in subjects with partial seizures.
- Conditions
- Epilepsy, Partial Seizure Disorder, Epilepsies, Partial, Complex Partial Seizure Disorder
- Trial name
- NCT00537940
- Testing
- Pregabalin, Gabapentin
- Where
- 8 sites in Costa Rica, El Salvador and 2 more
- Volunteers
- 482 people
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Epilepsy
Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)
Trial N01395 is to evaluate the reduction of nonpsychotic behavioral side effects in subjects with Epilepsy who switched to BRV 200 mg/day after discontinuing LEV due to such side effects; as well as the efficacy, safety and…
- Trial name
- NCT01653262
- Testing
- Brivaracetam
- Where
- 12 sites in United States, France and 3 more
- Volunteers
- 29 people
- Sponsor
- UCB Pharma SA
Epilepsy
Transcutaneous Vagal Nerve Stimulation: Influence on miRNA, Inflammation, Cerebral Resting State and Gastric Motility
Randomized, double-blind trial to investigate the influence of a single 4 hours episode of transcutaneous vagal nerve stimulation on the expression of microRNA, various cytokines, chemokines, neuropeptides, cerebral resting state…
- Trial name
- EpimiRNA_D (NCT02359188)
- Testing
- Transcutaneous vagal nerve stimulation
- Where
- Germany
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Philipps University Marburg
Epilepsy, Complex Partial
Neural Correlates of Cognition and Mood
The overall objective of this study is to determine the neural correlates of cognition and mood. This study represents the first preliminary study to begin investigating cognitive and emotional states in patients who have…
- Trial name
- NCT04573569
- Testing
- Behavioral testing
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- University of Minnesota
Benign Epilepsy With Centrotemporal Spikes, Language Problems
Transcranial Magnetic Stimulation for BECTS
Benign epilepsy with centrotemporal spikes (BECTS) is the most common pediatric epilepsy syndrome. Affected children typically have a mild seizure disorder, but yet have moderate difficulties with language, learning and attention…
- Conditions
- Benign Epilepsy With Centrotemporal Spikes, Language Problems, Learning Disorders
- Trial name
- TMS4BECTS (NCT04325282)
- Testing
- Active rTMS
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- Stanford University
Adenylosuccinate Lyase Deficiency
Evaluation of a Treatment With Allopurinol in Adenylosuccinate Lyase Deficiency
The aim of this study is to evaluate the effectiveness of allopurinol treatment at 12 months on the adaptive and cognitive functioning of patients with adenylosuccinate lyase deficiency (ADSL).
- Trial name
- ADSL (NCT03776656)
- Testing
- Allopurinol
- Where
- 2 sites in France
- Volunteers
- 8 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Seizures, Epilepsy
Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions
The objective of this study was to assess bioequivalence of a potential generic 600 mb oxcarbazepine tablet formulation compared with Novartis Pharmaceutical's 600 mg oxcarbazepine tablet, Trileptal, following a single 600 mg…
- Trial name
- NCT00618046
- Testing
- Oxcarbazepine
- Where
- United States
- Volunteers
- 48 people
- Sponsor
- Roxane Laboratories
Epilepsies, Partial
Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study
The purpose of this pilot study is to describe the relationship of regional cerebral oximetry and cytoximetry, measured using near-infrared spectroscopy, with seizure activity in the periictal period in children with epilepsy.
- Trial name
- NCT03054961
- Testing
- Near-infrared spectroscopy
- Where
- United States
- Volunteers
- 34 people
- Sponsor
- Medical College of Wisconsin
Epilepsy
Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate
Zonisamide (Zonegran) and sodium valproate (Epilim) are both medicines approved to treat epilepsy. The purpose of this study is to find out the extent to which zonisamide may affect memory and concentration, compared to sodium…
- Trial name
- NCT00713622
- Testing
- Zonisamide, Sodium valproate
- Where
- 2 sites in Austria, Finland
- Volunteers
- 2 people
- Sponsor
- Eisai Limited
Epilepsy, Cysticercosis
Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis
OBJECTIVES: I. Determine the effect of antiparasitic treatment with albendazole on the severity and duration of epilepsy due to neurocysticercosis. II.
- Trial name
- NCT00004403
- Testing
- albendazole, dexamethasone, phenytoin
- Volunteers
- 120 people
- Sponsor
- Johns Hopkins University
Epilepsy
PET Study of the Nicotinic System in Epilepsy
Mutations in neuronal nicotinic acetylcholine receptors (nAChRs) have been identified in the autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).
- Trial name
- NICOPET (NCT03268369)
- Testing
- MRI of the brain, PET scan [18F]F-A-85380, PET scan [18F]FDG
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Fabienne PICARD
Epilepsy, Ictal/Post-ictal Hypoxemia
Efficacy of Fluoxetine Against Seizure-induced Central Apneas
Sudden unexpected death in epilepsy (SUDEP) is a tragic outcome of seizure disorders that primarily affect young adults suffering from refractory epilepsy. In this population, SUDEP incidence is estimated at 0.5%.
- Trial name
- FLUOXETINE (NCT02569970)
- Testing
- fluoxetine 20 mg
- Where
- France
- Volunteers
- 70 people
- Sponsor
- Hospices Civils de Lyon
Epilepsy, Epilepsies, Partial
Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients
The purpose of this study is to assess a possible predictor for weight loss seen in epilepsy patients treated with topiramate.
- Conditions
- Epilepsy, Epilepsies, Partial, Epilepsy, Generalized, Seizures
- Trial name
- NCT00236886
- Testing
- topiramate
- Volunteers
- 49 people
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Benign Epilepsy With Centrotemporal Spikes
18F-FDG PET Imaging Analysis of Antiepileptic Drug Response in BECTS
This original article is a novel investigation on the metabolic characteristics of different patterns of antiepileptic drug (AED) responses in benign epilepsy with centrotemporal spikes (BECTS) patients using 18F-FDG PET imaging.
- Trial name
- NCT04357236
- Where
- China
- Volunteers
- 55 people
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Epilepsy, Seizures
Ketogenic Diet for Child Epilepsy and Seizure Control
Twenty to thirty percent of children with epilepsy continue to suffer from seizures, even when treated with currently available anticonvulsant medications.
- Conditions
- Epilepsy, Seizures, Lennox-Gastaut Syndrome
- Trial name
- NCT00004729
- Testing
- Ketogenic diet
- Where
- United States
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
Epilepsy
Comparison of Quality of Life and Changes Experienced by Patients After Epilepsy Surgery
Epilepsy is one of the most common chronic neurological diseases. According to data from the World Health Organization (WHO), it affects 0.5 to 1% of the population, or around 70 million people world-wide and around 600,000 in…
- Trial name
- EPICHANGE (NCT06035965)
- Testing
- Epilepsy Surgery Satisfaction Questionnaire (ESSQ-19), Quality of Life in Epilepsy Inventory (QOLIE-31), Generalized Anxiety Disorder 7 (GAD7)
- Where
- France
- Volunteers
- 151 people
- Sponsor
- University Hospital, Toulouse
Epilepsies, Focal
Subcutaneous EEG: Forecasting of Epileptic Seizures
Protocol Summary Population - Target population is 10 adults (18 to 75 years of age) with a diagnosis of treatment-resistant epilepsy with at least 20 seizures per year, and whose seizure onset recorded from scalp EEG is…
- Trial name
- SUBER (NCT04061707)
- Where
- United Kingdom
- Volunteers
- 15 people
- Sponsor
- King's College London
Epileptic Encephalopathy of Unindentified Genetic Origin
Evaluation of the Diagnostic Contribution of High-throughput Exome Sequencing for Patients With Convulsive Encephalopathy of Unknown Etiology: Pilot Study to Improve Genetic Counselling
Congenital epileptic encephalopathies (EE) are predominantly genetic in origin. Their diagnosis is hampered by the large number of genes involved and their low recurrence.
- Trial name
- SHD-EE (NCT03652246)
- Where
- France
- Volunteers
- 15 people
- Sponsor
- Centre Hospitalier Universitaire Dijon
Epilepsy, Brain Diseases
Mindfulness-based Intervention to Promote Psychological Wellbeing in People With Epilepsy
The efficacy of mindfulness-based intervention (MBI) for epilepsy has yet to be thoroughly investigated. Hence, the aim of the present study is to examine the effects of MBI on the psychological wellbeing of people with epilepsy…
- Conditions
- Epilepsy, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases
- Trial name
- NCT04313686
- Testing
- Mindfulness-based therapy, No-intervention
- Where
- Malaysia
- Volunteers
- 10 people
- Sponsor
- University of Malaya
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.